English  |  正體中文  |  简体中文  |  Items with full text/Total items : 17524/19853 (88%)
Visitors : 6390372      Online Users : 666
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
Scope Tips:
  • please add "double quotation mark" for query phrases to get precise results
  • please goto advance search for comprehansive author search
  • Adv. Search
    HomeLoginUploadHelpAboutAdminister Goto mobile version
    Please use this identifier to cite or link to this item: http://ir.cnu.edu.tw/handle/310902800/32678


    標題: The burdens of tuberculosis on patients with malignancy: incidence, mortality and relapse
    作者: Shu, Chin-Chung
    Liao, Kuang-Ming
    Chen, Yi-Chen
    Wang, Jhi-Joung
    Chung-Han Ho(何宗翰)
    貢獻者: Natl Taiwan Univ Hosp, Dept Internal Med
    Natl Taiwan Univ, Coll Med
    Chi Mei Med Ctr, Dept Internal Med
    Chi Mei Med Ctr, Dept Med Res
    Southern Taiwan Univ Sci & Technol, Al Biomed Ctr
    Chia Nan Univ Pharm & Sci, Dept Hosp & Hlth CareAdm
    關鍵字: LUNG-CANCER PATIENTS
    ACTIVE TUBERCULOSIS
    RISK
    INFECTION
    TB
    MULTICENTER
    SURVIVAL
    日期: 2019-08
    上傳時間: 2020-07-29 13:54:56 (UTC+8)
    出版者: NATURE PUBLISHING GROUP
    摘要: Population with malignancy is growing worldwide; however, its tuberculosis (TB) burden including remains unclear regarding incidence, mortality, and relapse. We retrieved information and identified patients with malignancy and TB between 2000 and 2015 from the Taiwanese National Health Insurance reimbursement datasets, Taiwan cancer registry and death registration. We analyzed the incidence of new TB in patients with malignancy and their mortality as well as TB recurrence. During study period, we reviewed 1,105,009 patients after exclusion and among them, 19,906 had newly diagnosed TB. The TB incidence in cancer patients divided all TB events increased annually, from 3% in 2000 to 13% in 2015. The standard incidence rates (SIR) were highest in cancer of respiratory tract (5.45), hematology (3.70) and then head and neck area (2.58). The mortality directly due to TB was defined as 0.83% and all-cause mortality were approximately 10.5% at 3 months and 20.56% at 12 months. After completing TB treatment, recurrence was diagnosed in 626 (3.14%), and 1001 (5.03%) patients within the first and the first two years, respectively. In conclusion, the incidence of TB in patients with malignancy increase yearly as well as its proportion within overall cases. The twelve-month all-cause mortality during TB and the two-year recurrence are as high as 20.56% and 5.03%, respectively. It indicates the importance of this population in future TB control, especially for those with malignancy of respiratory tract, and hematology as well as head and neck area.
    關聯: Scientific Reports, v.9, n11901
    Appears in Collections:[醫務管理系(所)] 期刊論文

    Files in This Item:

    File Description SizeFormat
    10.1038-s41598-019-48395-8.pdf1093KbAdobe PDF14View/Open
    index.html0KbHTML23View/Open


    All items in CNU IR are protected by copyright, with all rights reserved.


    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - Feedback